help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on March 4, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-2701
A more recent version of this article appeared on May 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/5/1901    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by MENASSA, R.
Right arrow Articles by MOREL, Y.
PubMed
Right arrow PubMed Citation
Right arrow Articles by MENASSA, R.
Right arrow Articles by MOREL, Y.
Related Collections
Right arrow Adrenal and Hypertension
Right arrow Pediatric Endocrinology

Submitted on December 7, 2007
Accepted on February 27, 2008

p.H62L, a rare mutation of the CYP21 gene identified in two forms of 21-hydroxylase deficiency

R. MENASSA, V. TARDY*, F. DESPERT, C. BOUVATTIER-MOREL, J. P. BROSSIER, M. CARTIGNY, and Y. MOREL

Laboratoire d'Endocrinologie Moléculaire et Maladies Rares, Centre de Biologie et de Pathologie Est, Bron, France; Centre de Pédiatrie, Centre Hospitalier Universitaire de Tours, Tours, France; Centre de Pédiatrie, Groupe Hospitalier Cochin St Vincent de Paul, Paris, France; Service de Pédiatrie-Néonatologie, Centre Hospitalier La Roche sur Yon, France; Endocrinologie, Centre de pédiatrie Hôpital Jeanne de Flandre Lille, France

* To whom correspondence should be addressed. E-mail: veronique.tardy{at}chu-lyon.fr.

Context: Steroid 21-hydroxylase deficiency is the most common enzymatic defect causing congenital adrenal hyperplasia with good genotype/phenotype relationships for common mutations. To determine the severity of rare mutations is essential for genetic counseling and better understanding of the structure-function of the cytochrome P450c21.

Objective: The p.H62L mutation was the most frequent of 60 new mutations detected in 2,900 21OHD patients, either isolated or associated on the same allele with a mild mutation (p.P453S, p.P30L or partial promoter). As phenotype seemed to differ between patients with isolated or associated p.H62L, a detailed phenotype description and functional studies were performed.

Results: Phenotype: Patients with isolated p.H62L had a non-classical form while patients with the association p.H62L + mild mutation had a simple virilizing form. Functional studies: p.H62L reduced the conversion of the 2 substrates, Progesterone and 17OHProgesterone, in the same way as the mild p.P453S; the association p.H62L + p.P453S decreased enzymatic activity more strongly while conserving residual activity at a level intermediate between p.P453S and p.I172N. This suggested that p.H62L was a mild mutation while a synergistic effect occurred when it was associated. Analysis of p.H62L in a three-dimensional model structure of the CYP21 protein explained the observed in vitro effects, the H62 being located in a domain implied in membrane anchoring.

Conclusion: According to phenotype and functional studies, p.H62L is a mild mutation, responsible for a more severe phenotype when associated with another mild mutation. These data are important for patients management and genetic counseling.


Key words: CYP21A2 • novel mutation • H62L • synergestic effect




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
F. C. Soardi, M. Barbaro, I. F. Lau, S. H. V. Lemos-Marini, M. T. M. Baptista, G. Guerra-Junior, A. Wedell, S. Lajic, and M. P. de Mello
Inhibition of CYP21A2 Enzyme Activity Caused by Novel Missense Mutations Identified in Brazilian and Scandinavian Patients
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2416 - 2420.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society